Robin Shane Readnour Sells 6,100 Shares of Anthem (NASDAQ:ANTX) Stock

Posted by Stanley Muller on Sep 8th, 2026

Anthem, Inc. (NASDAQ:ANTX – Get Free Report) Director Robin Shane Readnour sold 6,100 shares of the company’s stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $6.07, for a total transaction of $37,027.00. Following the sale, the director directly owned 562,715 shares of the company’s stock, valued at $3,415,680.05. The trade was a 1.07% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Robin Shane Readnour also recently made the following trade(s):

On Tuesday, September 8th, Robin Shane Readnour sold 10,019 shares of Anthem stock. The stock was sold at an average price of $6.02, for a total transaction of $60,314.38.
On Monday, August 17th, Robin Shane Readnour sold 35,402 shares of Anthem stock. The stock was sold at an average price of $6.01, for a total transaction of $212,766.02.

Anthem Price Performance

ANTX traded up $0.09 on Tuesday, reaching $5.98. 335,287 shares of the company’s stock were exchanged, compared to its average volume of 213,148. Anthem, Inc. has a twelve month low of $1.00 and a twelve month high of $7.19. The stock has a market cap of $225.69 million, a PE ratio of -5.59 and a beta of -0.99. The stock’s fifty day moving average price is $5.33 and its 200-day moving average price is $4.41.

Anthem (NASDAQ:ANTX – Get Free Report) last released its quarterly earnings data on Tuesday, August 11th. The company reported ($0.18) EPS for the quarter.

Analyst Upgrades and Downgrades

ANTX has been the topic of a number of analyst reports. Weiss Ratings reiterated a “sell (d-)” rating on shares of Anthem in a research report on Monday, July 6th. Guggenheim started coverage on Anthem in a research note on Monday, July 20th. They issued a “buy” rating and a $9.00 target price for the company. Leerink Partners raised Anthem from a “market perform” rating to an “outperform” rating and set a $9.00 target price for the company in a research note on Thursday, May 14th. Finally, Wall Street Zen upgraded Anthem from a “sell” rating to a “hold” rating in a report on Sunday, June 14th. Two research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat.com, Anthem presently has an average rating of “Hold” and a consensus target price of $9.00.

View Our Latest Report on Anthem

Institutional Investors Weigh In On Anthem

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Vivo Capital LLC purchased a new position in shares of Anthem during the 1st quarter worth $10,785,000. Commodore Capital LP acquired a new stake in shares of Anthem during the 1st quarter worth about $7,981,000. Spruce Street Capital LP purchased a new stake in Anthem in the 1st quarter valued at about $5,576,000. Ally Bridge Group NY LLC acquired a new position in Anthem in the first quarter valued at about $1,800,000. Finally, Seven Fleet Capital Management LP purchased a new position in Anthem during the first quarter worth about $683,000. Hedge funds and other institutional investors own 90.47% of the company’s stock.

About Anthem

(Get Free Report)

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products.